Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 6/2008

01.08.2008 | ORIGINAL PAPER

Pituitary volumes in relatives of bipolar patients

High-risk study

verfasst von: Tomas Hajek, MD, PhD, Eva Gunde, BSc, Denise Bernier, BSc, Claire Slaney, RN, Lukas Propper, MD, Glenda MacQueen, MD, PhD, Anne Duffy, MD, Martin Alda, MD

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Increased, decreased, as well as unchanged pituitary volumes have been reported in bipolar disorders (BD). It is unclear, whether abnormal pituitary volumes increase vulnerability for BD (primary vulnerability marker), or are secondary to burden of illness. To address this question, we performed the first high-risk study of pituitary volumes in affected and unaffected relatives of bipolar subjects.

Method

High-risk participants (age range 15–30 years) were recruited from families multiply affected with BD and included 24 unaffected, 19 affected subjects with first or second degree bipolar I or II relative, matched by age and sex with 31 controls without a personal or family history of psychiatric disorders. Pituitary volumes were measured on 1.5 T 3D anatomical MRI images using standard methods.

Results

We found comparable pituitary volumes among unaffected, affected relatives of bipolar patients and controls. There were no differences in pituitary volumes between male and female subjects nor was there any sex by group interaction. Analyzing 26 participants with bipolar I parent or excluding 5 medicated subjects did not change the results. There were no differences between subjects from families containing bipolar I versus families containing only bipolar II subjects.

Conclusions

The lack of abnormalities in unaffected and also affected subjects early in the course of illness in our study, as well as previous investigations of bipolar and familial unipolar children and adolescents, suggest that pituitary volume abnormalities are unlikely to be a primary risk factor for mood disorders.
Literatur
1.
Zurück zum Zitat Axelson DA, Doraiswamy PM, Boyko OB, Rodrigo EP, McDonald WM, Ritchie JC et al (1992) In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Res 44:63–70PubMedCrossRef Axelson DA, Doraiswamy PM, Boyko OB, Rodrigo EP, McDonald WM, Ritchie JC et al (1992) In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Res 44:63–70PubMedCrossRef
2.
Zurück zum Zitat Beresford T, Arciniegas D, Rojas D, Sheeder J, Teale P, Aasal R et al (1999) Hippocampal to pituitary volume ratio: a specific measure of reciprocal neuroendocrine alterations in alcohol dependence. J Stud Alcohol 60:586–588PubMed Beresford T, Arciniegas D, Rojas D, Sheeder J, Teale P, Aasal R et al (1999) Hippocampal to pituitary volume ratio: a specific measure of reciprocal neuroendocrine alterations in alcohol dependence. J Stud Alcohol 60:586–588PubMed
3.
Zurück zum Zitat Bielau H, Trubner K, Krell D, Agelink MW, Bernstein HG, Stauch R et al (2005) Volume deficits of subcortical nuclei in mood disorders: a postmortem study. Eur Arch Psychiatry Clin Neurosci 255:401–412PubMedCrossRef Bielau H, Trubner K, Krell D, Agelink MW, Bernstein HG, Stauch R et al (2005) Volume deficits of subcortical nuclei in mood disorders: a postmortem study. Eur Arch Psychiatry Clin Neurosci 255:401–412PubMedCrossRef
4.
Zurück zum Zitat Chen HH, Nicoletti M, Sanches M, Hatch JP, Sassi RB, Axelson D et al (2004) Normal pituitary volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study. Depress Anxiety 20:182–186PubMedCrossRef Chen HH, Nicoletti M, Sanches M, Hatch JP, Sassi RB, Axelson D et al (2004) Normal pituitary volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study. Depress Anxiety 20:182–186PubMedCrossRef
5.
Zurück zum Zitat Cox RW (1996) AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29:162–173PubMedCrossRef Cox RW (1996) AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29:162–173PubMedCrossRef
6.
Zurück zum Zitat Czeh B, Lucassen PJ (2007) What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 257:250–260PubMedCrossRef Czeh B, Lucassen PJ (2007) What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 257:250–260PubMedCrossRef
7.
Zurück zum Zitat Duffy A, Alda M, Kutcher S, Cavazzoni P, Robertson C, Grof E et al (2002) A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment. J Clin Psychiatry 63:1171–1178PubMed Duffy A, Alda M, Kutcher S, Cavazzoni P, Robertson C, Grof E et al (2002) A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment. J Clin Psychiatry 63:1171–1178PubMed
8.
Zurück zum Zitat Endicott J, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837–844PubMed Endicott J, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837–844PubMed
9.
Zurück zum Zitat Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B et al (2005) Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry 58:417–423PubMedCrossRef Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B et al (2005) Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry 58:417–423PubMedCrossRef
10.
Zurück zum Zitat Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W et al (1982) A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 39:1157–1167PubMed Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W et al (1982) A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 39:1157–1167PubMed
11.
Zurück zum Zitat Gispert JD, Reig S, Pascau J, Vaquero JJ, Garcia-Barreno P, Desco M (2004) Method for bias field correction of brain T1-weighted magnetic resonance images minimizing segmentation error. Hum Brain Mapp 22:133–144PubMedCrossRef Gispert JD, Reig S, Pascau J, Vaquero JJ, Garcia-Barreno P, Desco M (2004) Method for bias field correction of brain T1-weighted magnetic resonance images minimizing segmentation error. Hum Brain Mapp 22:133–144PubMedCrossRef
12.
Zurück zum Zitat Hajek T, Carrey N, Alda M (2005) Neuroanatomical abnormalities as risk factors for bipolar disorder. Bipolar Disord 7:393–403PubMedCrossRef Hajek T, Carrey N, Alda M (2005) Neuroanatomical abnormalities as risk factors for bipolar disorder. Bipolar Disord 7:393–403PubMedCrossRef
13.
Zurück zum Zitat Hajek T, Gunde E, Bernier D, Slaney C, Propper L, Grof P et al (2007) Subgenual cingulate volumes in affected and unaffected offspring of bipolar parents. J Affect Disord (in press) Hajek T, Gunde E, Bernier D, Slaney C, Propper L, Grof P et al (2007) Subgenual cingulate volumes in affected and unaffected offspring of bipolar parents. J Affect Disord (in press)
14.
Zurück zum Zitat Hoschl C, Hajek T (2001) Hippocampal damage mediated by corticosteroids–a neuropsychiatric research challenge. Eur Arch Psychiatry Clin Neurosci 251(Suppl 2):II81–II88PubMed Hoschl C, Hajek T (2001) Hippocampal damage mediated by corticosteroids–a neuropsychiatric research challenge. Eur Arch Psychiatry Clin Neurosci 251(Suppl 2):II81–II88PubMed
15.
Zurück zum Zitat Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P et al (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988PubMedCrossRef Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P et al (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988PubMedCrossRef
16.
Zurück zum Zitat Krishnan KR, Doraiswamy PM, Lurie SN, Figiel GS, Husain MM, Boyko OB et al (1991) Pituitary size in depression. J Clin Endocrinol Metab 72:256–259PubMedCrossRef Krishnan KR, Doraiswamy PM, Lurie SN, Figiel GS, Husain MM, Boyko OB et al (1991) Pituitary size in depression. J Clin Endocrinol Metab 72:256–259PubMedCrossRef
17.
Zurück zum Zitat Maas DL, Hunt S, Mark L, Drobny EC (1996) Reversible thioridazine-induced magnetic resonance imaging-documented pituitary enlargement associated with hyperprolactinemia. Endocr Pract 2:85–89PubMed Maas DL, Hunt S, Mark L, Drobny EC (1996) Reversible thioridazine-induced magnetic resonance imaging-documented pituitary enlargement associated with hyperprolactinemia. Endocr Pract 2:85–89PubMed
18.
Zurück zum Zitat MacMaster FP, El Sheikh R, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan M (2007) Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study. Schizophr Res 92:207–210PubMedCrossRef MacMaster FP, El Sheikh R, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan M (2007) Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study. Schizophr Res 92:207–210PubMedCrossRef
19.
Zurück zum Zitat MacMaster FP, Kusumakar V (2004) MRI study of the pituitary gland in adolescent depression. J Psychiatr Res 38:231–236PubMedCrossRef MacMaster FP, Kusumakar V (2004) MRI study of the pituitary gland in adolescent depression. J Psychiatr Res 38:231–236PubMedCrossRef
20.
Zurück zum Zitat MacMaster FP, Russell A, Mirza Y, Keshavan MS, Taormina SP, Bhandari R et al (2006) Pituitary volume in treatment-naive pediatric major depressive disorder. Biol Psychiatry 60:862–866PubMedCrossRef MacMaster FP, Russell A, Mirza Y, Keshavan MS, Taormina SP, Bhandari R et al (2006) Pituitary volume in treatment-naive pediatric major depressive disorder. Biol Psychiatry 60:862–866PubMedCrossRef
21.
Zurück zum Zitat McDonald C, Marshall N, Sham PC, Bullmore ET, Schulze K, Chapple B et al (2006) Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry 163:478–487PubMedCrossRef McDonald C, Marshall N, Sham PC, Bullmore ET, Schulze K, Chapple B et al (2006) Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry 163:478–487PubMedCrossRef
22.
Zurück zum Zitat Oren DA, Levendosky AA, Kasper S, Duncan CC, Rosenthal NE (1996) Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder. Biol Psychiatry 39:157–170PubMedCrossRef Oren DA, Levendosky AA, Kasper S, Duncan CC, Rosenthal NE (1996) Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder. Biol Psychiatry 39:157–170PubMedCrossRef
23.
Zurück zum Zitat Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C et al (2005) Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 30:1923–1931PubMedCrossRef Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C et al (2005) Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 30:1923–1931PubMedCrossRef
24.
Zurück zum Zitat Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ et al (2004) Pituitary volume in psychosis. Br J Psychiatry 185:5–10PubMedCrossRef Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ et al (2004) Pituitary volume in psychosis. Br J Psychiatry 185:5–10PubMedCrossRef
25.
Zurück zum Zitat Phillips ML, Drevets WC, Rauch SL, Lane R (2003) Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 54:515–528PubMedCrossRef Phillips ML, Drevets WC, Rauch SL, Lane R (2003) Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 54:515–528PubMedCrossRef
26.
Zurück zum Zitat Rubin RT, Phillips JJ, Sadow TF, McCracken JT (1995) Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 52:213–218PubMed Rubin RT, Phillips JJ, Sadow TF, McCracken JT (1995) Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 52:213–218PubMed
27.
Zurück zum Zitat Sassi RB, Nicoletti M, Brambilla P, Harenski K, Mallinger AG, Frank E et al (2001) Decreased pituitary volume in patients with bipolar disorder. Biol Psychiatry 50:271–280PubMedCrossRef Sassi RB, Nicoletti M, Brambilla P, Harenski K, Mallinger AG, Frank E et al (2001) Decreased pituitary volume in patients with bipolar disorder. Biol Psychiatry 50:271–280PubMedCrossRef
28.
Zurück zum Zitat Schwartz PJ, Loe JA, Bash CN, Bove K, Turner EH, Frank JA et al (1997) Seasonality and pituitary volume. Psychiatry Res 74:151–157PubMedCrossRef Schwartz PJ, Loe JA, Bash CN, Bove K, Turner EH, Frank JA et al (1997) Seasonality and pituitary volume. Psychiatry Res 74:151–157PubMedCrossRef
29.
Zurück zum Zitat Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE (1999) Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease. Biol Psychiatry 46:1595–1602PubMedCrossRef Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE (1999) Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease. Biol Psychiatry 46:1595–1602PubMedCrossRef
30.
Zurück zum Zitat Todd RD, Reich W, Petti TA, Joshi P, DePaulo JR Jr, Nurnberger J Jr et al (1996) Psychiatric diagnoses in the child and adolescent members of extended families identified through adult bipolar affective disorder probands. J Am Acad Child Adolesc Psychiatry 35:664–671PubMedCrossRef Todd RD, Reich W, Petti TA, Joshi P, DePaulo JR Jr, Nurnberger J Jr et al (1996) Psychiatric diagnoses in the child and adolescent members of extended families identified through adult bipolar affective disorder probands. J Am Acad Child Adolesc Psychiatry 35:664–671PubMedCrossRef
31.
Zurück zum Zitat Weber-Hamann B, Hentschel F, Kniest A, Deuschle M, Colla M, Lederbogen F et al (2002) Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 64:274–277PubMed Weber-Hamann B, Hentschel F, Kniest A, Deuschle M, Colla M, Lederbogen F et al (2002) Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 64:274–277PubMed
Metadaten
Titel
Pituitary volumes in relatives of bipolar patients
High-risk study
verfasst von
Tomas Hajek, MD, PhD
Eva Gunde, BSc
Denise Bernier, BSc
Claire Slaney, RN
Lukas Propper, MD
Glenda MacQueen, MD, PhD
Anne Duffy, MD
Martin Alda, MD
Publikationsdatum
01.08.2008
Verlag
D. Steinkopff-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 6/2008
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-008-0804-0

Weitere Artikel der Ausgabe 6/2008

European Archives of Psychiatry and Clinical Neuroscience 6/2008 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.